Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-12-21
1999-10-26
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514171, 514177, 514179, 514181, 552507, 552548, 552553, 552594, 552608, 552610, C07J 3100, C07J 900, C07J 5100, A61K 3156
Patent
active
059729228
ABSTRACT:
Novel angiostatic .DELTA..sup.4,9(11) -steroids (I), ##STR1## C.sub.21 -oxygenated steroids (II) and other known steroidal compounds have been found to be useful in treating angiogenesis in mammals who have a need for the same. These steroids are useful in treating diseases of neovascularization such as cancer, diabetes and arthritis.
REFERENCES:
patent: 3067193 (1962-12-01), Tishler et al.
patent: 3067194 (1962-12-01), Tishler et al.
patent: 3158601 (1964-11-01), Buchschacher et al.
patent: 3291815 (1966-12-01), Pinson, Jr.
patent: 3300483 (1967-01-01), Tishler et al.
patent: 3980778 (1976-09-01), Ayer et al.
patent: 4018918 (1977-04-01), Ayer et al.
patent: 4041055 (1977-08-01), Shephard et al.
patent: 4599331 (1986-07-01), Schreiber et al.
patent: 4704358 (1987-11-01), Kominek et al.
patent: 4771042 (1988-09-01), Braughler et al.
patent: 4975537 (1990-12-01), Aristoff et al.
patent: 5001116 (1991-03-01), Folkman et al.
Steroid Drugs, 1962, McGraw-Hill Book Company Inc. p. 3.
Science 221:719 (1983).
Folkman, et al., Annals of Surgery 206:374-383 (1987).
Coffey, R.J., J. Cell Physiol. 132:143-148 (1987).
J. National Cancer Institute, 81:1346-1351 (1989).
Gross, et al., Proc. National Academy of Sciences USA, 78:1176-1180 (1981).
Oikawa, et al., Cancer Letters, 43:85-92 (1988).
Ziche, et al., International Journal of Cancer, 35:549-552 (1985).
Penhallgon, et al., J. National Cencer Institute, 74:869-873 (1985).
Lee, Cancer Research, 47:5021-5024 (1987).
Teale, et al., European Journal of Cancer and Clinical Oncology 23:93-100 (1987).
J. Org. Chem., 33:1700 (1968).
Kano, et al., J. Org. Chem., 44(9):1582-1584 (1970).
Jacobsen, et al., J. Med. Chem., 33:1145-1151 (1990).
Van Rheenen et al. J.O.C., 44(9), 1582-4, 1979.
Drayer et al. Steroids, 44(4), 293-300, 1984.
Aristoff Paul A.
DeKoning Thomas F.
Wilks John W.
Alcon Laboratories Inc.
Coleman Brenda
Shah Mukund J.
Yeager Sally
LandOfFree
Steroids which inhibit angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroids which inhibit angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroids which inhibit angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764725